TABLE 1.
Resistance to:a | Human isolates (n = 243)
|
Chicken isolates (n = 93)
|
P valueb | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
No antibiotic agents | 13 | 5.3 | 2 | 2.2 | NS |
Colistin | 4 | 1.6 | 15 | 16.1 | <0.001 |
Polymyxin B | 0 | 0 | 14 | 15.1 | <0.001 |
Ampicillin | 31 | 12.8 | 19 | 20.7 | NS |
Neomycin | 1 | 0.4 | 4 | 4.3 | NS |
Gentamicin | 1 | 0.4 | 0 | 0.0 | NS |
Nalidixic acid | 221 | 90.9 | 86 | 92.5 | NS |
Trimethoprim-sulfamethoxazole | 113 | 46.5 | 52 | 55.9 | NS |
Tetracycline | 124 | 51.0 | 59 | 63.4 | 0.05 |
Chloramphenicol | 85 | 35.0 | 37 | 39.8 | NS |
Streptomycin | 125 | 51.4 | 48 | 51.6 | NS |
Ciprofloxacin | 0 | 0 | 0 | 0 | NS |
Ceftriaxone | 0 | 0 | 0 | 0 | NS |
≥4 Antibiotic agents | 113 | 46.5 | 52 | 55.9 | NS |
Antibiotics and the amounts in disks were as follows: chloramphenicol, nalidixic acid, neomycin, ceftriaxone, tetracycline, and polymyxin B, 30 μg each; ampicillin, streptomycin, and colistin, 10 μg each; ciprofloxacin and gentamicin, 5 μg each; trimethoprim-sulfamethoxazole 1:19, 25 μg. The quality control strains that were used for the susceptibility testing are Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853.
NS, not significant. For all NS cell entries, the difference between human isolates and chicken isolates is not statistically significant (P > 0.05).